Cargando…

Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice

BACKGROUND: Human cytomegalovirus (HCMV) causes serious HCMV-related diseases in immunocompromised people. Vaccination is the most effective measure to control infection with the pathogen, yet no vaccine has been licensed till now. We performed a head-to-head comparison of the protective abilities o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chaoyang, Wang, Huadong, Wu, Shuting, Chang, Haiyan, Liu, Lalan, Peng, Bo, Fang, Fang, Chen, Ze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073173/ https://www.ncbi.nlm.nih.gov/pubmed/24898886 http://dx.doi.org/10.1186/1743-422X-11-104

Ejemplares similares

Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody
por: Chen, Jianjun, et al.
Publicado: (2007)

Complete Protection of Mice against Lethal Murine Cytomegalovirus Challenge by Immunization with DNA Vaccines Encoding Envelope Glycoprotein Complex III Antigens gH, gL and gO
por: Wang, Huadong, et al.
Publicado: (2015)

An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV
por: Wang, Huadong, et al.
Publicado: (2014)

Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice
por: Kaur, Sukhbir, et al.
Publicado: (2016)

A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus
por: Chang, Haiyan, et al.
Publicado: (2010)

Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice
por: Han, Yali, et al.
Publicado: (2017)

SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice
por: Zhou, Jian, et al.
Publicado: (2017)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice
por: Milovanovic, Jelena, et al.
Publicado: (2017)

DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice
por: Sun, Xi-Meng, et al.
Publicado: (2011)

Recombinant PAL/PilE/FlaA DNA vaccine provides protective immunity against Legionella pneumophila in BALB/c mice
por: Chen, Yingying, et al.
Publicado: (2020)

Oral Vaccination with Attenuated Salmonella typhimurium-Delivered TsPmy DNA Vaccine Elicits Protective Immunity against Trichinella spiralis in BALB/c Mice
por: Wang, Lei, et al.
Publicado: (2016)

Induction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1
por: Sonaimuthu, Parthasarathy, et al.
Publicado: (2016)

Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Recombinant Toxoplasma gondii MIF, CDPK3, and 14-3-3 Protein Cocktail Vaccine
por: Liu, Fang, et al.
Publicado: (2021)

Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis
por: Arnold, Isabelle C., et al.
Publicado: (2015)

Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor
por: Liu, Kang, et al.
Publicado: (2019)

Protection of BALB/c mice against pathogenic Brucella abortus and Brucella melitensis by vaccination with recombinant Omp16
por: Alizadeh, Hamed, et al.
Publicado: (2019)

The Leishmania HSP20 Is Antigenic during Natural Infections, but, as DNA Vaccine, It does not Protect BALB/c Mice against Experimental L. amazonensis Infection
por: Montalvo-Álvarez, Ana M., et al.
Publicado: (2008)

Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha
por: Wang, Shuai, et al.
Publicado: (2015)

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice
por: Wang, Hai-Long, et al.
Publicado: (2016)

Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice
por: Hsieh, Ao-Ho, et al.
Publicado: (2011)

Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection
por: de Matos Guedes, Herbert Leonel, et al.
Publicado: (2014)

GrpE Immunization Protects Against Ureaplasma urealyticum Infection in BALB/C Mice
por: Tang, Yanhong, et al.
Publicado: (2020)

Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice
por: Martínez-Rodrigo, Abel, et al.
Publicado: (2019)

Protection against homo and hetero-subtypic inﬂuenza A virus by optimized M2e DNA vaccine
por: Yao, Yanfeng, et al.
Publicado: (2019)

Oral vaccination with Trichinella spiralis DNase II DNA vaccine delivered by attenuated Salmonella induces a protective immunity in BALB/c mice
por: Qi, Xin, et al.
Publicado: (2018)

Molecular identification of Trichinella spiralis nudix hydrolase and its induced protective immunity against trichinellosis in BALB/c mice
por: Long, Shao Rong, et al.
Publicado: (2014)

Response to 'Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice'
por: Kim, Gn, et al.
Publicado: (2012)

Immunogenicity of Multiepitope Vaccine Candidate against Toxoplasma gondii Infection in BALB/c Mice
por: HAJISSA, Khalid, et al.
Publicado: (2018)

Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice
por: Soto, Manuel, et al.
Publicado: (2015)

Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice
por: Liu, Yuan, et al.
Publicado: (2017)

Vaccination against the human cytomegalovirus
por: Plotkin, Stanley A., et al.
Publicado: (2019)

B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice
por: HoHsieh, Ao, et al.
Publicado: (2017)

Biochemical studies on the protective effect of honey against doxorubicin-induced toxicity in BALB/C mice
por: Alhumaydhi, Fahad A.
Publicado: (2020)

Protective Effect of Anoectochilus formosanus Polysaccharide against Cyclophosphamide-Induced Immunosuppression in BALB/c Mice
por: Xie, Anqi, et al.
Publicado: (2023)

Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
por: Mazumder, Saumyabrata, et al.
Publicado: (2011)

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice
por: Zheng, Liyun, et al.
Publicado: (2009)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

Protective Immunity against Chlamydia psittaci Lung Infection Induced by a DNA Plasmid Vaccine Carrying CPSIT_p7 Gene Inhibits Dissemination in BALB/c Mice
por: Wang, Chuan, et al.
Publicado: (2023)

Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice
por: Salari, Samira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v1on870l6oslkf3iq4enlhb4is